AIM
TECH icon

Artemis Investment Management’s Bio-Techne TECH Stock Holding History

Artemis Investment Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-224,775
Closed -$16.6M – 237
2023
Q1 		$16.6M Sell
224,775
-253,286
-53% -$19.5M 0.2% 120
2022
Q4 		$39.7M Sell
478,061
-21,107
-4% -$1.68M 0.45% 65
2022
Q3 		$35.5M Sell
499,168
-296,804
-37% -$25.6M 0.4% 76
2022
Q2 		$69.1M Sell
795,972
-57,692
-7% -$5.41M 0.71% 47
2022
Q1 		$92.3M Sell
853,664
-419,800
-33% -$43.3M 0.74% 35
2021
Q4 		$165M Buy
1,273,464
+52,212
+4% +$6.4M 1.2% 18
2021
Q3 		$148M Buy
1,221,252
+97,608
+9% +$11.9M 1.17% 18
2021
Q2 		$127M Buy
1,123,644
+643,408
+134% +$67.7M 1.09% 20
2021
Q1 		$45.8M Buy
+480,236
New +$43.8M 0.43% 67

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Artemis Investment Management's TECH Position: Q2 2023 in Review

Artemis Investment Management sold out of Bio-Techne (TECH) in Q2 2023, closing a stake of 224,775 shares — an estimated $16.6M sold.

Artemis Investment Management first reported a position in TECH in Q1 2021 and held it in 9 quarters. The position peaked at $165M in Q4 2021. 529 funds tracked by Wall St. Rank hold TECH as of Q2 2023.

  • Artemis Investment Management reported no remaining Bio-Techne position as of Q2 2023 after selling out during the quarter.
  • Artemis Investment Management sold 224,775 Bio-Techne shares in Q2 2023, an estimated $16.6M.
  • Artemis Investment Management first reported a position in Bio-Techne in Q1 2021 and held it in 9 quarters.
  • Artemis Investment Management's Bio-Techne position peaked at $165M in Q4 2021.
  • 529 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2023.

Based on Artemis Investment Management's 13F filing for Q2 2023, filed 19 Jul 2023.